Understanding The Functions of BCL7C: A Potential Drug Target

Target Name: BCL7C

NCBI ID: G9274

BCL7C

Understanding The Functions of BCL7C: A Potential Drug Target

BCL7C (SMARCJ3) is a protein that is expressed in various tissues throughout the body, including the lungs, heart, kidneys, and gastrointestinal tract. It is a member of the SMARCJ family of proteins, which are known as scaffold proteins that play a crucial role in organizing and supporting various cellular structures. One of the unique features of BCL7C is its ability to interact with other proteins, including the transcription factor ASXL1, which has been shown to play a role in the regulation of gene expression and cell signaling.

In addition to its role in cellular signaling, BCL7C has also been shown to be involved in the regulation of cellular processes that are important for tissue repair and regeneration. For example, studies have shown that BCL7C is involved in the regulation of cell proliferation and differentiation, as well as the regulation of cell death.

Despite its importance in a wide range of cellular processes, BCL7C is not yet a well-studied protein. There are only a few studies that have investigated its role in specific cellular processes, and more research is needed to fully understand its functions and potential as a drug target.

One potential mechanism by which BCL7C could be targeted as a drug is through its role in the regulation of cell signaling. Many diseases, including cancer, are caused by the disruption of normal cellular signaling processes. As such, drugs that can act to restore or inhibit signaling processes can be effective in treating a wide range of diseases.

In particular, BCL7C has been shown to play a role in the regulation of cell signaling by ASXL1. This protein is a transcription factor that is involved in the regulation of gene expression and cell signaling. Studies have shown that BCL7C and ASXL1 can interact and that ASXL1 can cause BCL7C to adopt a specific conformational state that is different from its natural state.

One possible explanation for the interaction between BCL7C and ASXL1 is that BCL7C plays a role in the regulation of ASXL1 activity. This could involve the regulation of ASXL1 stability or the modulation of its activity by other proteins.

Another potential mechanism by which BCL7C could be targeted as a drug is through its role in the regulation of cell death. Many diseases, including cancer, are caused by the disruption of normal cellular processes that control cell death. As such, drugs that can act to restore or inhibit these processes can be effective in treating a wide range of diseases.

Studies have shown that BCL7C is involved in the regulation of cell death by several different processes. For example, BCL7C has been shown to play a role in the regulation of apoptosis, which is a normal form of cell death that is involved in the elimination of damaged or dysfunctional cells.

One possible explanation for the role of BCL7C in cell death is that it acts as a regulator of the execution of cell death processes. This could involve the regulation of the release of cellular signaling molecules, such as caspases and ethosinases, which are involved in the execution of apoptosis.

In addition to its potential roles in cell signaling and cell death, BCL7C has also been shown to play a role in the regulation of cellular processes that are important for tissue repair and regeneration. This is an area of ongoing research, and more studies are needed to fully understand the functions of BCL7C in these processes.

Overall, while BCL7C is an important protein that is involved in a wide range of cellular processes, there is still much to be learned about its functions and potential as a drug target. Further research is needed to fully understand the role of BCL7C in cellular signaling, cell death, and tissue repair and regeneration.

Protein Name: BAF Chromatin Remodeling Complex Subunit BCL7C

Functions: May play an anti-apoptotic role

The "BCL7C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BCL7C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets